A major exchange-traded fund provider is going deep on two popular plays: megacap tech and weight loss drug stocks. In health care, Roundhill Investments is getting ready to launch a fund that focuses on the companies behind GLP-1 drugs. Dave Mazza, the firm’s chief strategy officer, expects to have more information on the fund’s debut … Read more
Check out the companies making headlines in midday trading. Victoria’s Secret – The intimate apparel retailer shed 36% and headed for its worst day on record after posting mixed fourth-quarter results and disappointing guidance. Victoria’s Secret said it anticipates a larger-than-expected decline in revenues for the first quarter and full year. Novo Nordisk — Shares … Read more
Check out the companies making headlines before the bell: Novo Nordisk — Shares jumped 6.6% after the Danish pharmaceutical company reported positive Phase 1 trial data for its new experimental obesity drug, amycretin. Eli Lilly, the company’s American rival, dipped 0.7% on the news. Nvidia — Semiconductor companies rose broadly as a group, with the … Read more
Check out the companies making headlines in midday trading. Nvidia — The chipmaker climbed nearly 5% and reached an all-time high after Goldman Sachs increased its price target to $800 per share from $625. Catalent , Novo Nordisk — The contract drug manufacturer climbed about 10% on the back of an agreement to get taken … Read more